Compare WYETH LTD with Procter & Gamble Health - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH LTD vs PROCTER & GAMBLE HEALTH - Comparison Results

WYETH LTD     Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

PROCTER & GAMBLE HEALTH 
   Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WYETH LTD PROCTER & GAMBLE HEALTH WYETH LTD/
PROCTER & GAMBLE HEALTH
 
P/E (TTM) x 27.7 55.4 50.0% View Chart
P/BV x 5.3 5.0 106.7% View Chart
Dividend Yield % 1.3 9.5 13.5%  

Financials

 WYETH LTD   PROCTER & GAMBLE HEALTH
EQUITY SHARE DATA
    WYETH LTD
Mar-13
PROCTER & GAMBLE HEALTH
Dec-18
WYETH LTD/
PROCTER & GAMBLE HEALTH
5-Yr Chart
Click to enlarge
High Rs1,0443,549 29.4%   
Low Rs8181,301 62.9%   
Sales per share (Unadj.) Rs298.6511.4 58.4%  
Earnings per share (Unadj.) Rs57.261.3 93.4%  
Cash flow per share (Unadj.) Rs58.474.0 78.9%  
Dividends per share (Unadj.) Rs17.00440.00 3.9%  
Dividend yield (eoy) %1.818.1 10.1%  
Book value per share (Unadj.) Rs249.5927.8 26.9%  
Shares outstanding (eoy) m22.7216.60 136.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.14.7 65.8%   
Avg P/E ratio x16.339.6 41.1%  
P/CF ratio (eoy) x15.932.8 48.7%  
Price / Book Value ratio x3.72.6 142.8%  
Dividend payout %29.7717.9 4.1%   
Avg Mkt Cap Rs m21,15740,257 52.6%   
No. of employees `0000.51.1 43.4%   
Total wages/salary Rs m4001,313 30.5%   
Avg. sales/employee Rs Th13,787.47,486.7 184.2%   
Avg. wages/employee Rs Th813.01,157.6 70.2%   
Avg. net profit/employee Rs Th2,643.3897.2 294.6%   
INCOME DATA
Net Sales Rs m6,7838,490 79.9%  
Other income Rs m353244 144.6%   
Total revenues Rs m7,1368,734 81.7%   
Gross profit Rs m1,6171,482 109.2%  
Depreciation Rs m27211 12.6%   
Interest Rs m60-   
Profit before tax Rs m1,9381,514 128.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-566 -7.8%   
Tax Rs m632563 112.4%   
Profit after tax Rs m1,3011,017 127.8%  
Gross profit margin %23.817.5 136.6%  
Effective tax rate %32.637.1 87.8%   
Net profit margin %19.212.0 160.0%  
BALANCE SHEET DATA
Current assets Rs m6,98415,343 45.5%   
Current liabilities Rs m2,0561,960 104.9%   
Net working cap to sales %72.6157.6 46.1%  
Current ratio x3.47.8 43.4%  
Inventory Days Days9949 203.7%  
Debtors Days Days2428 84.2%  
Net fixed assets Rs m2441,209 20.2%   
Share capital Rs m227166 136.9%   
"Free" reserves Rs m5,44115,235 35.7%   
Net worth Rs m5,66815,401 36.8%   
Long term debt Rs m250-   
Total assets Rs m7,90117,595 44.9%  
Interest coverage x353.3NM-  
Debt to equity ratio x00-  
Sales to assets ratio x0.90.5 177.9%   
Return on assets %16.55.8 285.9%  
Return on equity %22.96.6 347.3%  
Return on capital %34.010.3 331.9%  
Exports to sales %0.20-   
Imports to sales %36.30-   
Exports (fob) Rs m15NA-   
Imports (cif) Rs m2,465NA-   
Fx inflow Rs m151,636 0.9%   
Fx outflow Rs m2,6774,368 61.3%   
Net fx Rs m-2,662-2,732 97.4%   
CASH FLOW
From Operations Rs m923-1,304 -70.8%  
From Investments Rs m31712,697 2.5%  
From Financial Activity Rs m-481-301 160.1%  
Net Cashflow Rs m75911,093 6.8%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 51.1 51.8 98.6%  
Indian inst/Mut Fund % 11.3 18.2 62.1%  
FIIs % 7.2 1.0 720.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 29.1 104.5%  
Shareholders   21,978 28,591 76.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WYETH LTD With:   J.B.CHEMICALS  SUVEN LIFESCIENCES  IPCA LABS  CADILA HEALTHCARE  VENUS REMEDIES  

Compare WYETH LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Jumps 1,921 Points, FM's Tax Relief, and Top Cues in Focus Today(Pre-Open)

Share markets in India jumped sharply on Friday after Finance Minister Nirmala Sitharaman announced a slew of measures in her media briefing ahead of the GST Council meet.

Related Views on News

PROCTER & GAMBLE HEALTH Announces Quarterly Results (1QFY20); Net Profit Up 34.3% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 441 m (up 34.3% YoY). Sales on the other hand came in at Rs 2 bn (up 6.1% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

PROCTER & GAMBLE HEALTH 2017-18 Annual Report Analysis (Annual Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

Here's an analysis of the annual report of PROCTER & GAMBLE HEALTH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PROCTER & GAMBLE HEALTH. Also includes updates on the valuation of PROCTER & GAMBLE HEALTH.

MERCK Announces Quarterly Results (4QFY19); Net Profit Up 79.2% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, MERCK has posted a net profit of Rs 407 m (up 79.2% YoY). Sales on the other hand came in at Rs 2 bn (down 23.3% YoY). Read on for a complete analysis of MERCK's quarterly results.

MERCK LTD Announces Quarterly Results (3QFY19); Net Profit Up 31.3% (Quarterly Result Update)

Mar 5, 2019 | Updated on Mar 5, 2019

For the quarter ended December 2018, MERCK LTD has posted a net profit of Rs 135 m (up 31.3% YoY). Sales on the other hand came in at Rs 2 bn (down 32.8% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

MERCK LTD Announces Quarterly Results (2QFY19); Net Profit Up 29.8% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, MERCK LTD has posted a net profit of Rs 411 m (up 29.8% YoY). Sales on the other hand came in at Rs 2 bn (down 27.7% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

My 7 Stocks to Buy Are Companies Which Will Be a Big Part of New India(The 5 Minute Wrapup)

Sep 19, 2019

The India we knew is changing. Here's how you can benefit from this change.

Did the Tax Bonanza Really Deserve a 2,000-point Gain on the Sensex?(Profit Hunter)

Sep 20, 2019

Are investors overdoing their euphoria post the corporate tax cut bonanza?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

WYETH LTD SHARE PRICE


Dec 9, 2014 (Close)

TRACK WYETH LTD

  • Track your investment in WYETH LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE WYETH LTD WITH

MARKET STATS